Picton Mahoney Asset Management Lowers Stake in UnitedHealth Group Incorporated (UNH)
Picton Mahoney Asset Management cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 139,300 shares of the healthcare conglomerate’s stock after selling 1,875 shares during the quarter. UnitedHealth Group accounts for 1.8% of Picton Mahoney Asset Management’s holdings, making the stock its 9th largest position. Picton Mahoney Asset Management’s holdings in UnitedHealth Group were worth $25,829,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $110,000. Kings Point Capital Management increased its holdings in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $121,000. 86.20% of the stock is currently owned by institutional investors.
Several brokerages have recently commented on UNH. Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a research note on Friday, December 1st. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Jefferies Group reissued a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research note on Friday, December 1st. Finally, Piper Jaffray Companies lifted their price objective on shares of UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a research note on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $224.56.
UnitedHealth Group Incorporated (UNH) traded down $0.15 during midday trading on Thursday, hitting $219.94. 2,397,400 shares of the company’s stock were exchanged, compared to its average volume of 3,116,121. The company has a market capitalization of $213,282.06, a PE ratio of 22.93, a PEG ratio of 1.63 and a beta of 0.66. UnitedHealth Group Incorporated has a 12-month low of $156.09 and a 12-month high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.17 earnings per share. analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other news, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now owns 36,989 shares in the company, valued at $8,218,955.80. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 62,606 shares of company stock worth $12,677,525. 0.89% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://theolympiareport.com/2017/12/07/picton-mahoney-asset-management-lowers-stake-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.